Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Evolva SA - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Evolva SA - Product Pipeline Review - 2014', provides an overview of the Evolva SA's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Evolva SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Evolva SA including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Evolva SA's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Evolva SA's pipeline products Reasons to buy - Evaluate Evolva SA's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Evolva SA in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Evolva SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Evolva SA and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Evolva SA - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Evolva SA and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Evolva SA Snapshot 4 Evolva SA Overview 4 Key Information 4 Key Facts 4 Evolva SA - Research and Development Overview 5 Key Therapeutic Areas 5 Evolva SA - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Evolva SA - Pipeline Products Glance 12 Evolva SA - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Evolva SA - Drug Profiles 13 EV-009 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 EV-021 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 EV-035 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 EV-075 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 EV-086 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Evolva SA - Pipeline Analysis 19 Evolva SA - Pipeline Products by Target 19 Evolva SA - Pipeline Products by Route of Administration 20 Evolva SA - Pipeline Products by Molecule Type 21 Evolva SA - Pipeline Products by Mechanism of Action 22 Evolva SA - Recent Pipeline Updates 23 Evolva SA - Dormant Projects 24 Evolva SA - Discontinued Pipeline Products 25 Discontinued Pipeline Product Profiles 25 EV-086 25 Evolva SA - Locations And Subsidiaries 26 Head Office 26 Other Locations & Subsidiaries 26 Appendix 27 Methodology 27 Coverage 27 Secondary Research 27 Primary Research 27 Expert Panel Validation 27 Contact Us 28 Disclaimer 28
List of Tables Evolva SA, Key Information 4 Evolva SA, Key Facts 4 Evolva SA - Pipeline by Indication, 2014 7 Evolva SA - Pipeline by Stage of Development, 2014 8 Evolva SA - Monotherapy Products in Pipeline, 2014 9 Evolva SA - Out-Licensed Products in Pipeline, 2014 10 Evolva SA - Out-Licensed Products/ Combination Treatment Modalities, 2014 11 Evolva SA - Preclinical, 2014 12 Evolva SA - Pipeline by Target, 2014 19 Evolva SA - Pipeline by Route of Administration, 2014 20 Evolva SA - Pipeline by Molecule Type, 2014 21 Evolva SA - Pipeline Products by Mechanism of Action, 2014 22 Evolva SA - Recent Pipeline Updates, 2014 23 Evolva SA - Dormant Developmental Projects,2014 24 Evolva SA - Discontinued Pipeline Products, 2014 25 Evolva SA, Subsidiaries 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.